{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:22:32Z","timestamp":1784071352605,"version":"3.55.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81570043"],"award-info":[{"award-number":["81570043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010855","name":"Jiangsu Provincial Department of Human Resources and Social Security","doi-asserted-by":"crossref","award":["ZDA2020016"],"award-info":[{"award-number":["ZDA2020016"]}],"id":[{"id":"10.13039\/501100010855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Pulmonary veno-occlusive disease (PVOD) is a kind of rare and fatal pulmonary arterial hypertension (PAH). Different from other subtypes of PAH, PVOD patients have a very poor prognosis because of the progressive nature of pulmonary vascular involvement and fatal pulmonary edema induced by PAH-targeted drugs. Lung transplantation is the only choice for these patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported 2 cases of PVOD which was misdiagnosed as idiopathic pulmonary arterial hypertension initially due to the lack of typical findings of PVOD. Right heart catheterization was done. The results showed severe PAH with mean pulmonary artery pressure at 76\u200ammHg and 68\u200ammHg.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The diagnosis of idiopathic pulmonary arterial hypertension was corrected by eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4) mutation screening. Biallelic mutations (c.1387delT (p. Arg463fs); c.989-990 delAA (p. Lys330fs)) were detected by next-generation sequencing for whole exome from blood sample. The presence of biallelic EIF2AK4 mutation was sufficient to confirm the diagnosis of PVOD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The 2 patients had good response to PAH-targeted therapy (Ambrisentan 10\u200amg once a day and tadalafil 20\u200amg once a day) in the following 1\u200ayear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Because the patients had a good response to targeted drugs, the treatment of the 2 cases was unchanged. Over 1-year period, they still have a good response to PAH-targeted drugs. There was no sign of pulmonary edema.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>All these results may indicate that PVOD is not so rare and typical findings of PVOD are lacking in some patients. EIF2AK4 mutation screening by next-generation sequencing maybe useful to differentiate PVOD from other PAH subtypes. PVOD is a heterogeneity population and different patients have different characteristics including response to PAH-targeted therapy. How to pick off this portion of patients timely is the core issue. Further study is necessary to answer this question.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027334","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T22:26:28Z","timestamp":1637706388000},"page":"e27334","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7178-1196","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Respiratory medicine, Zhongda Hospital of Southeast University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Zhongda Hospital of Southeast University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory medicine, Zhongda Hospital of Southeast University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"R1-20250504","first-page":"100","article-title":"Zur histologie der klinischen \u201cprimaren pulmonalsklerose\u201d [On the histology of clinical primary pulmonary sclerosis]","volume":"47","author":"H\u00f6ra","year":"1934","journal-title":"Frankf Z Pathol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/LBR.0000000000000320","article-title":"Small sample lung biopsy findings in patients with clinicoradiologic suspicion of pulmonary venoocclusive diseasepulmonary capillary hemangiomatosis","volume":"23","author":"Bal","year":"2016","journal-title":"J Bronchology Interv Pulmonol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary venoocclusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1586\/ers.11.15","article-title":"Pulmonary veno-occlusive disease: advances in clinical management and treatments","volume":"5","author":"Huertas","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1164\/ajrccm.162.5.9912045","article-title":"Pulmonary veno-occlusive disease","volume":"162","author":"Mandel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12890-020-01179-7","article-title":"Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants [J]","volume":"20","author":"Zeng","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"(suppl)","key":"R10-20250504","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.34.2.242","article-title":"Pulmonary veno-occlusive disease","volume":"34","author":"Heath","year":"1966","journal-title":"Circulation"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng.2844","article-title":"EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension","volume":"46","author":"Eyries","year":"2014","journal-title":"Nat Genet"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.rmed.2010.03.014","article-title":"Pulmonary veno-occlusive disease: Recent progress and current challenges","volume":"104","author":"David","year":"2010","journal-title":"Respir Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1183\/13993003.00717-2015","article-title":"Genetic counselling in a national referral centre for pulmonary hypertention","volume":"47","author":"Girerd","year":"2016","journal-title":"Eur Respir J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.117.028351","article-title":"Phenotypic characterization of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension","volume":"136","author":"Hadinnapola","year":"2017","journal-title":"Circulation"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease[J]","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1164\/ajrccm.162.5.9912045","article-title":"Pulmonary veno-occlusive disease[J]","volume":"162","author":"Mandel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1161\/CIRCULATIONAHA.114.006974","article-title":"Advances in therapeutic interventions for patients with pulmonary arterial hypertension","volume":"130","author":"Humbert","year":"2014","journal-title":"Circulation"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1753465812468042","article-title":"A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges","volume":"7","author":"Sourla","year":"2013","journal-title":"Ther Adv Respir Dis"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.34501","article-title":"Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension","volume":"64","author":"G\u00fcnther","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1183\/09031936.00017809","article-title":"Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thx.2007.088831","article-title":"Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil","volume":"63","author":"Creagh-Brown","year":"2008","journal-title":"Thorax"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12890-019-1031-3","article-title":"Targeted therapy in pulmonary veno-occlusive disease: time for a rethink [J]","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Pulm Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.117.028351","article-title":"Phenotypic characterisation of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension","volume":"136","author":"Hadinnapola","year":"2017","journal-title":"Circulation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:39:21Z","timestamp":1746333561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027334"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":27,"journal-issue":{"issue":"41","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027334","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"2021-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}